Log in
Enquire now
Velano Vascular

Velano Vascular

Velano Vascular is a med-tech company that developed blood-draw technology and products. The company was acquired by Becton Dickinson in July 2021.

OverviewStructured DataIssuesContributors
Is a
Organization
Organization
Company
Company
Acquisition Transaction
‌
Acquisition of Velano Vascular by Becton Dickinson
AngelList URL
angel.co/velano-vascular-1
Country
United States
United States
Crunchbase URL
crunchbase.com/organiz...vascular
Full Address
221 Pine St, #200, San Francisco, California 94104, US
0
Industry
Engineering
Engineering
Medical device
Medical device
Biomedical engineering
Biomedical engineering
Healthcare
Healthcare
Health technology
Health technology
Biotechnology
Biotechnology
Invested in
Intermountain Healthcare
Intermountain Healthcare
Eastward Capital Partners
Eastward Capital Partners
Kapor Capital
Kapor Capital
Investors
White Owl Capital Partners
White Owl Capital Partners
0
Safeguard Scientifics
Safeguard Scientifics
First Round Capital
First Round Capital
0
Latest Funding Round Date
May 8, 2019
Latest Funding Round Amount (USD)
10,000,000
LinkedIn URL
@company/velanovascular
Location
San Francisco
San Francisco
California
California
Number of Employees (Ranges)
51 – 200
0
Patents Assigned (Count)
4
Public/Private
Private
0
Total Funding Amount (USD)
27,000,000
Twitter URL
@velanovascular
Official Website
velanovascular.com
Wellfound ID
velano-vascular-1

Find more companies like Velano Vascular

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.